Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3707 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

AstraZeneca brain tumor drug shows promise

Researchers at Massachusetts General Hospital and Harvard Medical School also said that the imaging and biomarker studies they performed as treatment was underway have revealed why the treatment,

Avanir pain drug successful in late-stage trial

The drug met the primary endpoint and both Zenvia treatment groups had lower pain ratings than placebo patients. Zenvia also demonstrated statistically significant improvements in a number of

Introgen presents positive cancer gene results

The company said the cancer-suppressing gene, FUS1, has been successfully delivered into the tumors of lung cancer patients via its lipid nanoparticle product candidate. In a phase I

Glaxo gets approval for two drugs in Japan

Advair, which will be marketed as Adoair Diskus, has been approved for adult patients with bronchial asthma when concomitant use of an inhaled corticosteroid and long-acting beta-agonist is

GSK cancer vaccine demonstrates 100% protection

GlaxoSmithKline said the trial results demonstrate the longest duration of protection seen in any cervical cancer vaccine trial reported to date. The data was from an extended follow-up

Scolr Pharma pain drug effective

Scolr Pharma is also making available previously non-disclosed information about progress of its product with the potential to be the first extended-release ibuprofen tablet formulation for the US

Merck applies for expanded Gardasil label

Gardasil is cleared as a vaccine against four strains of the human papillomavirus, or HPV. The new submission for Gardasil includes efficacy data showing some protection against additional